These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7365374)

  • 1. The ED01 study: introduction, objectives, and experimental design.
    Cairns T
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):1-7. PubMed ID: 7365374
    [No Abstract]   [Full Text] [Related]  

  • 2. The ED01 study: summary and conclusions.
    Gaylor DW
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):179-83. PubMed ID: 7365380
    [No Abstract]   [Full Text] [Related]  

  • 3. Innovations in cancer risk assessment (Ed study). Proceedings of a symposium sponsored by National Center for Toxicological Research, U.S. Food and Drug Administration, the American College of Toxicology.
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):1-246. PubMed ID: 7365373
    [No Abstract]   [Full Text] [Related]  

  • 4. Thresholds of carcinogenicity in the ED01 study.
    Andersen ME; Conolly RB; Gaylor DW
    Toxicol Sci; 2003 Aug; 74(2):486-7; author reply 487-8. PubMed ID: 12874369
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence of a "clear and consistent threshold" for bladder and liver cancer in the large ED01 carcinogenicity study.
    Crump KS; Clewell HJ
    Toxicol Sci; 2003 Aug; 74(2):485; author reply 485-6. PubMed ID: 12730607
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis of animal carcinogenicity experiments with multiple tumor types.
    Lu Y; Malani HM
    Biometrics; 1995 Mar; 51(1):73-86. PubMed ID: 7766797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-examination of the ED01 study. Overview.
    Fundam Appl Toxicol; 1981; 1(1):28-63. PubMed ID: 7184773
    [No Abstract]   [Full Text] [Related]  

  • 8. Biological model of ED01 hepatocarcinogenesis.
    Travis CC; Zeng C; Nicholas J
    Toxicol Appl Pharmacol; 1996 Sep; 140(1):19-29. PubMed ID: 8806866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thresholds in carcinogenicity in ED01 study.
    Rozman KK
    Toxicol Sci; 2003 Sep; 75(1):224-5. PubMed ID: 12923303
    [No Abstract]   [Full Text] [Related]  

  • 10. Re-examination of the ED01 study--risk assessment using time.
    Fundam Appl Toxicol; 1981; 1(1):88-123. PubMed ID: 7184778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Waddell's representation of the tumor incidence data of the ED01 study is strongly misleading.
    Lutz WK
    Toxicol Sci; 2003 Sep; 75(1):223; author reply 223-4. PubMed ID: 12923302
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronic dose-response studies in mice fed 2-AAF.
    Littlefield NA; Cueto C; Davis AK; Medlock K
    J Toxicol Environ Health; 1975 Sep; 1(1):25-37. PubMed ID: 1185817
    [No Abstract]   [Full Text] [Related]  

  • 13. Re-examination of the ED01 study. Audit of pathology.
    Fundam Appl Toxicol; 1981; 1(1):64-6. PubMed ID: 7184774
    [No Abstract]   [Full Text] [Related]  

  • 14. Re-examination of the ED01 study - adjusting for time on study.
    Fundam Appl Toxicol; 1981; 1(1):67-80. PubMed ID: 7184775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologic and morphologic characteristics of urinary bladder neoplasms induced in BALB/c female mice with 2-acetylaminofluorene.
    Frith CH; Farmer JH; Greenman DL; Shaw GW
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):103-19. PubMed ID: 7365375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dose and time in a long-term, low-dose carcinogenic study.
    Littlefield NA; Farmer JH; Gaylor DW; Sheldon WG
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):17-34. PubMed ID: 7365379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose and time responses models for the incidence of bladder and liver neoplasms in mice fed 2-acetylaminofluorene continuously.
    Farmer JH; Kodell RL; Greenman DL; Shaw GW
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):55-68. PubMed ID: 7365386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of agreement among findings of pathologists in ED01 experiment.
    Amato DA; Lagakos SW
    J Natl Cancer Inst; 1988 Aug; 80(12):919-25. PubMed ID: 3398066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thresholds of carcinogenicity in the ED01 study.
    Waddell WJ
    Toxicol Sci; 2003 Mar; 72(1):158-63. PubMed ID: 12604845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1984 Stokinger lecture. Some questions and opinions on issues in toxicology and risk assessment.
    Weil CS
    Am Ind Hyg Assoc J; 1984 Oct; 45(10):663-70. PubMed ID: 6496314
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.